Mar 4 | Scientific Lecture with Dr. Alfred Fonteh
The Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
A scientific seminar by Dr. Alfred Fonteh, PhD
When: Wednesday, March 4, 2026 from 3 to 4 PM
Where: HMRI Auditorium | 686 S. Fair Oaks Ave., Pasadena, CA 91105 (Zoom option available)
Who Should Attend: Scientists, researchers, and scientific enthusiasts
A leader in biomarker discovery and translational neuroscience, Dr. Fonteh investigates how lipid metabolism and bioenergetic dysfunction contribute to Alzheimer’s disease progression. In this talk, he will explore how changes in brain-derived lipids may serve as early, non-invasive indicators of disease risk and how these insights could inform emerging therapeutic and preventive strategies.
ABOUT THE SPEAKER
Alfred Fonteh, PhD, is Research Professor of Clinical and Translational Neurosciences at HMRI and leads the Biomarkers Neuro-Disease Mechanism Lab (BNML). His research focuses on uncovering the biological mechanisms underlying Alzheimer’s disease, with particular emphasis on identifying non-invasive biomarkers that can detect the disease in its earliest, preclinical stages before the onset of cognitive symptoms.
Dr. Fonteh’s lab investigates how alterations in lipid metabolism, mitochondrial dysfunction, and bioenergetic pathways contribute to disease progression. By studying lipid profiles across cognitively healthy individuals, those with mild cognitive impairment, and patients with Alzheimer’s disease, his team seeks to establish clear connections between measurable biomarkers and early pathology. Through close collaboration with clinical and analytical research partners at HMRI, his work aims to advance early diagnosis, inform therapeutic development, and expand opportunities for prevention.
In addition to his scientific leadership, Dr. Fonteh is committed to mentoring the next generation of researchers and fostering collaborative, translational research that bridges laboratory discovery and patient care.